Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07549126 · ClinicalTrials.gov registry record · NA
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 267
- Enrollment target
NCT07549126 is a NA study that has completed, run by Yale University. The registered enrollment target is 267 participants.
The verdict
NCT07549126, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 267 participants
- Enrollment target
Study Summary
This study is stage 2, round 1 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
Interventions
- OTHER Nurse prompt to complete COWS under required documentation
- OTHER Refined EMBED CDS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2026-04-02 |
| Est. Completion | 2026-05-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07549126
The ClinicalTrials.gov registry entry for NCT07549126 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 267 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nurse prompt to complete COWS under required documentation is the first listed.
NCT07549126 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07549126 about?
NCT07549126 is a clinical study titled "Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1". This study is stage 2, round 1 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
What is the current status of trial NCT07549126?
This trial is currently completed. It is a NA study. The enrollment target is 267 participants. The study started on 2026-04-02. Estimated completion is 2026-05-07.
What interventions are being tested in trial NCT07549126?
The interventions under investigation include: Nurse prompt to complete COWS under required documentation (OTHER), Refined EMBED CDS (OTHER).
Who is sponsoring clinical trial NCT07549126?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.